Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Delhi Territory India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Jammu & Kashmir India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Territory Sales Manager Cardio: Prague Prague Czech Republic International Innovative Medicines Sales Oct 14, 2024
Territory Sales Manager Immunology: Moravia Prague Czech Republic International Innovative Medicines Sales Oct 11, 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development May 28, 2024
Therapeutic Area Biomarker Lead, Director Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 21, 2024
Therapeutic Area Head Hematology (region LACan) East Hanover USA International Innovative Medicines Commercial & General Management Oct 14, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 03, 2024
Therapeutic Data Strategy Director East Hanover USA Development Innovative Medicines Research & Development Jul 02, 2024
Therapy Area Lead (ONCO/Hema & NS/Imm) Kyiv Ukraine International Innovative Medicines Commercial & General Management Apr 16, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Third Party Risk Management Specialist Prague Czech Republic Operations CTS Procurement Jul 30, 2024
Time Services Expert – US & Canada INSURGENTES Mexico People & Organization CTS Human Resources Oct 22, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Trainee Marketing (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Oct 18, 2024
Transformation Strategy Manager Jr Santo Amaro Brazil International Innovative Medicines Market Access Oct 25, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Treasury Cash Management Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 25, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 03, 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access Oct 18, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations Aug 19, 2024
UX/UI Designer Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
Validation Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Sep 03, 2024
Validation Expert İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Jul 22, 2024
Validation lead İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Jun 07, 2024
Validation Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 03, 2024
Value Access Manager Bogota (Oncology) / Cali (Pharmaceuticals) Colombia International Innovative Medicines Market Access Oct 10, 2024
Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 03, 2024
Vendor Alliance Lead Associate Director (Remote) East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Vendor Management & Governance Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 04, 2024
Vendor Management & Governance Manager Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 24, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Legal & Intellectual Property & Compl. Oct 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only